[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100580153":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":16,"locations":21,"responsibleParty":76,"collaborators":10,"id":78,"slug":79,"hasResults":80,"nctId":81,"briefTitle":82,"officialTitle":83,"acronym":84,"eligibilityCriteria":85,"healthyVolunteers":80,"sex":86,"minAge":87,"maxAge":10,"enrollmentInfo":88,"targetDuration":10,"studyType":91,"phases":10,"briefSummary":92,"conditions":93,"keywords":97,"overallStatus":24,"whyStopped":10,"lastUpdateSubmitDate":102,"lastUpdatePostDateStruct":103,"startDateStruct":106,"completionDateStruct":108,"leadSponsor":110,"locationsCount":111},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Adult with Enterococcus faecalis monomicrobial bloodstream infection",null,"Adult patients with primary Enterococcus faecalis monomicrobial bloodstream infection",[13],{"name":14,"affiliation":5,"role":15},"Maddalena Giannella, MD PhD","PRINCIPAL_INVESTIGATOR",[17],{"name":14,"role":18,"phone":19,"phoneExt":10,"email":20},"CONTACT","+39 0512143199","maddalena.giannella@unibo.it",[22,40,47,61],{"facility":23,"status":24,"city":25,"state":25,"zip":26,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Ospedale Maggiore \"Carlo Alberto Pizzardi\" di Bologna","RECRUITING","Bologna","40133","Italy","IT",{"type":30,"coordinates":31},"Point",[32,33],11.33875,44.49381,{"lat":33,"lon":32},[36],{"name":37,"role":18,"phone":38,"phoneExt":10,"email":39},"Luca Guerra, MD","+390515879975","luca.guerra@ausl.bologna.it",{"facility":5,"status":24,"city":25,"state":25,"zip":41,"country":27,"countryCode":28,"cosmosGeoPoint":42,"geoPoint":44,"contacts":45},"40138",{"type":30,"coordinates":43},[32,33],{"lat":33,"lon":32},[46],{"name":14,"role":18,"phone":19,"phoneExt":10,"email":20},{"facility":48,"status":24,"city":49,"state":49,"zip":50,"country":27,"countryCode":28,"cosmosGeoPoint":51,"geoPoint":55,"contacts":56},"Azienda Ospedaliero Universitaria di Catanzaro \"Mater Domini\"","Catanzaro","88100",{"type":30,"coordinates":52},[53,54],16.60086,38.88247,{"lat":54,"lon":53},[57],{"name":58,"role":18,"phone":59,"phoneExt":10,"email":60},"Alessandro Russo, MD","+3909613647552","a.russo@unicz.it",{"facility":62,"status":24,"city":63,"state":64,"zip":65,"country":27,"countryCode":28,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"Humanitas Research Hospital","Milan","Milano","20089",{"type":30,"coordinates":67},[68,69],12.59836,42.78235,{"lat":69,"lon":68},[72],{"name":73,"role":18,"phone":74,"phoneExt":10,"email":75},"Michele Bartoletti, MD","+390282243568","michele.bartoletti@hunimed.eu",{"type":77,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100580153","antimicrobial-combination-therapy-for-treatment-of-enterococcus-faecalis-bacteremia-100580153",false,"NCT06833593","Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia","Efficacy of Optimized Antimicrobial Combination Therapy for Treatment of Enterococcus Faecalis Bacteremia and Identification of Intestinal Microbiota Signature","MicroEFfAECT","Inclusion Criteria:\n\n* Adult (≥18 years)\n* Monomicrobial EF-BSI\n* Receipt of ≥ 5 days of at least one in vitro active drug (ampicillin, amoxicillin\u002Fclavulanate, ampicillin\u002Fsulbactam, piperacillin, vancomycin, teicoplanin, daptomycin and linezolid) with or without a synergistic drug (ceftriaxone, gentamycin, streptomycin), at common suggested dosages for EF-BSI in empirical or definitive therapy\n* Written informed consent\n\nExclusion Criteria:\n\n* Short term (within 3 days from BSI) mortality\n* Other concomitant infection","ALL","18 Years",{"count":89,"type":90},510,"ESTIMATED","OBSERVATIONAL","Prospective, multicenter, national, observational pharmacological study on the evaluation of efficacy of appropriate monotherapy vs combination treatment for non-complicated Enterococcus faecalis (EF) bloodstream infection (BSI) and identification of gut microbiota fingerprint of patients with EF-BSI correlated to antimicrobial treatment and clinical outcome",[94,95,96],"Enterococcus Faecalis Infection","Blood Stream Infection","Gut Microbiomes",[98,99,100,101],"Enterococcus faecalis bloodstream infection","Human tissue analysis in vitro","Gut microbiota analysis","Enterococcus faecalis genomic analysis","2025-11-26",{"date":104,"type":105},"2025-12-03","ACTUAL",{"date":107,"type":105},"2021-02-06",{"date":109,"type":90},"2026-09-26",{"name":5,"class":6},4]